Novel Combination of Sorafenib and Celecoxib Provides Synergistic Anti-Proliferative and Pro-Apoptotic Effects in Human Liver Cancer Cells
Melchiorre Cervello(Istituto di Biomedicina e di Immunologia Molecolare Alberto Monroy), Giuseppe Montalto(University of Palermo)
Cited by 50
Related Papers
NUPR1, a new target in liver cancer: implication in controlling cell growth, migration, invasion and sorafenib resistance
|Cell Death and Disease|2016|141
Oleocanthal exerts antitumor effects on human liver and colon cancer cells through ROS generation
|International Journal of Oncology|2017|94